Home > Balance Sheet > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹21 Cr₹16 Cr₹22 Cr₹13 Cr₹75 Cr

What is the latest Contingent Liabilities ratio of GLAND PHARMA ?

The latest Contingent Liabilities ratio of GLAND PHARMA is ₹21 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹21 Cr
Mar2024₹16 Cr
Mar2023₹22 Cr
Mar2022₹13 Cr
Mar2021₹75 Cr

How is Contingent Liabilities of GLAND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹21 Cr
37.24
Mar2024 ₹16 Cr
-29.41
Mar2023 ₹22 Cr
72.94
Mar2022 ₹13 Cr
-82.91
Mar2021 ₹75 Cr -

Compare Contingent Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹31,066.4 Cr -0.5% 11% 21.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,991.0 Cr 0.1% -3.2% -2.6% Stock Analytics
DIVIS LABORATORIES ₹162,371.0 Cr -1.5% -7.3% 2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,229.0 Cr -1.3% -0.7% 24.4% Stock Analytics
CIPLA ₹108,441.0 Cr 1.5% -8.1% -6.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,407.0 Cr 3.2% 5.6% 3.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-0.5%

11%

21.8%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses